Pre-transplant measurable residual disease by flow cytometry is an independent prognostic factor in pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation - Poll - MDSpire

Pre-transplant measurable residual disease by flow cytometry is an independent prognostic factor in pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

  • By

  • Shaoyang Deng

  • Shan He

  • Na Song

  • Zhijun Huang

  • Benshan Zhang

  • July 17, 2026

Share

Original Source(s)

Pre-transplant measurable residual disease by flow cytometry is an independent prognostic factor in pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

  • by Shaoyang Deng, Shan He, Na Song, Zhijun Huang, Benshan Zhang

  • July 17, 2026

Related Content

SMARCB1 (INI1)-deficient malignant melanocytic neoplasm with histologically confirmed vertebral metastases in a young adult: a case report

The dual role of parasites and parasite-derived products in cancer biology: a systematic review of in vitro and in vivo evidence

Age-stratified diagnostic performance of the ovarian-adnexal reporting and data system for adnexal masses: a focus on school-age children, early, and middle adolescents